Cargando…

Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using...

Descripción completa

Detalles Bibliográficos
Autores principales: Otake, Shiro, Chubachi, Shotaro, Namkoong, Ho, Nakagawara, Kensuke, Tanaka, Hiromu, Lee, Ho, Morita, Atsuho, Fukushima, Takahiro, Watase, Mayuko, Kusumoto, Tatsuya, Masaki, Katsunori, Kamata, Hirofumi, Ishii, Makoto, Hasegawa, Naoki, Harada, Norihiro, Ueda, Tetsuya, Ueda, Soichiro, Ishiguro, Takashi, Arimura, Ken, Saito, Fukuki, Yoshiyama, Takashi, Nakano, Yasushi, Mutoh, Yoshikazu, Suzuki, Yusuke, Murakami, Koji, Okada, Yukinori, Koike, Ryuji, Kitagawa, Yuko, Kimura, Akinori, Imoto, Seiya, Miyano, Satoru, Ogawa, Seishi, Kanai, Takanori, Fukunaga, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472186/
https://www.ncbi.nlm.nih.gov/pubmed/36104674
http://dx.doi.org/10.1186/s12879-022-07701-y
_version_ 1784789251915776000
author Otake, Shiro
Chubachi, Shotaro
Namkoong, Ho
Nakagawara, Kensuke
Tanaka, Hiromu
Lee, Ho
Morita, Atsuho
Fukushima, Takahiro
Watase, Mayuko
Kusumoto, Tatsuya
Masaki, Katsunori
Kamata, Hirofumi
Ishii, Makoto
Hasegawa, Naoki
Harada, Norihiro
Ueda, Tetsuya
Ueda, Soichiro
Ishiguro, Takashi
Arimura, Ken
Saito, Fukuki
Yoshiyama, Takashi
Nakano, Yasushi
Mutoh, Yoshikazu
Suzuki, Yusuke
Murakami, Koji
Okada, Yukinori
Koike, Ryuji
Kitagawa, Yuko
Kimura, Akinori
Imoto, Seiya
Miyano, Satoru
Ogawa, Seishi
Kanai, Takanori
Fukunaga, Koichi
author_facet Otake, Shiro
Chubachi, Shotaro
Namkoong, Ho
Nakagawara, Kensuke
Tanaka, Hiromu
Lee, Ho
Morita, Atsuho
Fukushima, Takahiro
Watase, Mayuko
Kusumoto, Tatsuya
Masaki, Katsunori
Kamata, Hirofumi
Ishii, Makoto
Hasegawa, Naoki
Harada, Norihiro
Ueda, Tetsuya
Ueda, Soichiro
Ishiguro, Takashi
Arimura, Ken
Saito, Fukuki
Yoshiyama, Takashi
Nakano, Yasushi
Mutoh, Yoshikazu
Suzuki, Yusuke
Murakami, Koji
Okada, Yukinori
Koike, Ryuji
Kitagawa, Yuko
Kimura, Akinori
Imoto, Seiya
Miyano, Satoru
Ogawa, Seishi
Kanai, Takanori
Fukunaga, Koichi
author_sort Otake, Shiro
collection PubMed
description BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using cluster analysis. METHODS: From April 2020 to May 2021, data from inpatients aged ≥ 18 years diagnosed with COVID-19 and who agreed to participate in the study were collected. A total of 1322 Japanese patients were included. Hierarchical cluster analysis was performed using variables reported to be associated with COVID-19 severity or prognosis, namely, age, sex, obesity, smoking history, hypertension, diabetes mellitus, malignancy, chronic obstructive pulmonary disease, hyperuricemia, cardiovascular disease, chronic liver disease, and chronic kidney disease. RESULTS: Participants were divided into four clusters: Cluster 1, young healthy (n = 266, 20.1%); Cluster 2, middle-aged (n = 245, 18.5%); Cluster 3, middle-aged obese (n = 435, 32.9%); and Cluster 4, elderly (n = 376, 28.4%). In Clusters 3 and 4, sore throat, dysosmia, and dysgeusia tended to be less frequent, while shortness of breath was more frequent. Serum lactate dehydrogenase, ferritin, KL-6, d-dimer, and C-reactive protein levels tended to be higher in Clusters 3 and 4. Although Cluster 3 had a similar age as Cluster 2, it tended to have poorer outcomes. Both Clusters 3 and 4 tended to exhibit higher rates of oxygen supplementation, intensive care unit admission, and mechanical ventilation, but the mortality rate tended to be lower in Cluster 3. CONCLUSIONS: We have successfully performed the first phenotyping of COVID-19 patients in Japan, which is clinically useful in predicting important outcomes, despite the simplicity of the cluster analysis method that does not use complex variables.
format Online
Article
Text
id pubmed-9472186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94721862022-09-14 Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics Otake, Shiro Chubachi, Shotaro Namkoong, Ho Nakagawara, Kensuke Tanaka, Hiromu Lee, Ho Morita, Atsuho Fukushima, Takahiro Watase, Mayuko Kusumoto, Tatsuya Masaki, Katsunori Kamata, Hirofumi Ishii, Makoto Hasegawa, Naoki Harada, Norihiro Ueda, Tetsuya Ueda, Soichiro Ishiguro, Takashi Arimura, Ken Saito, Fukuki Yoshiyama, Takashi Nakano, Yasushi Mutoh, Yoshikazu Suzuki, Yusuke Murakami, Koji Okada, Yukinori Koike, Ryuji Kitagawa, Yuko Kimura, Akinori Imoto, Seiya Miyano, Satoru Ogawa, Seishi Kanai, Takanori Fukunaga, Koichi BMC Infect Dis Research BACKGROUND: The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using cluster analysis. METHODS: From April 2020 to May 2021, data from inpatients aged ≥ 18 years diagnosed with COVID-19 and who agreed to participate in the study were collected. A total of 1322 Japanese patients were included. Hierarchical cluster analysis was performed using variables reported to be associated with COVID-19 severity or prognosis, namely, age, sex, obesity, smoking history, hypertension, diabetes mellitus, malignancy, chronic obstructive pulmonary disease, hyperuricemia, cardiovascular disease, chronic liver disease, and chronic kidney disease. RESULTS: Participants were divided into four clusters: Cluster 1, young healthy (n = 266, 20.1%); Cluster 2, middle-aged (n = 245, 18.5%); Cluster 3, middle-aged obese (n = 435, 32.9%); and Cluster 4, elderly (n = 376, 28.4%). In Clusters 3 and 4, sore throat, dysosmia, and dysgeusia tended to be less frequent, while shortness of breath was more frequent. Serum lactate dehydrogenase, ferritin, KL-6, d-dimer, and C-reactive protein levels tended to be higher in Clusters 3 and 4. Although Cluster 3 had a similar age as Cluster 2, it tended to have poorer outcomes. Both Clusters 3 and 4 tended to exhibit higher rates of oxygen supplementation, intensive care unit admission, and mechanical ventilation, but the mortality rate tended to be lower in Cluster 3. CONCLUSIONS: We have successfully performed the first phenotyping of COVID-19 patients in Japan, which is clinically useful in predicting important outcomes, despite the simplicity of the cluster analysis method that does not use complex variables. BioMed Central 2022-09-14 /pmc/articles/PMC9472186/ /pubmed/36104674 http://dx.doi.org/10.1186/s12879-022-07701-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Otake, Shiro
Chubachi, Shotaro
Namkoong, Ho
Nakagawara, Kensuke
Tanaka, Hiromu
Lee, Ho
Morita, Atsuho
Fukushima, Takahiro
Watase, Mayuko
Kusumoto, Tatsuya
Masaki, Katsunori
Kamata, Hirofumi
Ishii, Makoto
Hasegawa, Naoki
Harada, Norihiro
Ueda, Tetsuya
Ueda, Soichiro
Ishiguro, Takashi
Arimura, Ken
Saito, Fukuki
Yoshiyama, Takashi
Nakano, Yasushi
Mutoh, Yoshikazu
Suzuki, Yusuke
Murakami, Koji
Okada, Yukinori
Koike, Ryuji
Kitagawa, Yuko
Kimura, Akinori
Imoto, Seiya
Miyano, Satoru
Ogawa, Seishi
Kanai, Takanori
Fukunaga, Koichi
Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title_full Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title_fullStr Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title_full_unstemmed Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title_short Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics
title_sort clinical clustering with prognostic implications in japanese covid-19 patients: report from japan covid-19 task force, a nation-wide consortium to investigate covid-19 host genetics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472186/
https://www.ncbi.nlm.nih.gov/pubmed/36104674
http://dx.doi.org/10.1186/s12879-022-07701-y
work_keys_str_mv AT otakeshiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT chubachishotaro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT namkoongho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT nakagawarakensuke clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT tanakahiromu clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT leeho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT moritaatsuho clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT fukushimatakahiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT watasemayuko clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT kusumototatsuya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT masakikatsunori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT kamatahirofumi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT ishiimakoto clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT hasegawanaoki clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT haradanorihiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT uedatetsuya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT uedasoichiro clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT ishigurotakashi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT arimuraken clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT saitofukuki clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT yoshiyamatakashi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT nakanoyasushi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT mutohyoshikazu clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT suzukiyusuke clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT murakamikoji clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT okadayukinori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT koikeryuji clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT kitagawayuko clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT kimuraakinori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT imotoseiya clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT miyanosatoru clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT ogawaseishi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT kanaitakanori clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT fukunagakoichi clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics
AT clinicalclusteringwithprognosticimplicationsinjapanesecovid19patientsreportfromjapancovid19taskforceanationwideconsortiumtoinvestigatecovid19hostgenetics